Rishi K Jain Selected Research

GFB-204

7/2005

Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rishi K Jain Research Topics

Disease

5	Neoplasms (Cancer) 01/2019 - 05/2004
2	Carcinogenesis 07/2005 - 05/2004
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Autoimmune Diseases (Autoimmune Disease) 11/2005
1	Neoplasm Metastasis (Metastasis) 05/2004
1	Melanoma (Melanoma, Malignant) 05/2004

Drug/Important Bio-Agent (IBA)

2	Biological ProductsIBA 01/2019 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2005 - 05/2004
1	CalcineurinIBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	LignansIBA 01/2019
1	englerin AIBA 01/2015
1	cathepsin SIBA 11/2005
1	Cysteine Proteases (Cysteine Protease)IBA 11/2005
1	GFB-204IBA 07/2005
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2005
1	Platelet-Derived Growth FactorIBA 05/2004
1	GFA 116IBA 05/2004

Therapy/Procedure

2	Therapeutics 01/2021 - 07/2009
1	Surgical Instruments (Clip) 01/2015